Related Experiment Video
Updated: May 27, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
[Myotonic dystrophy type 2]
Takashi Kimura1, Tsukasa Saito
1Department of Neurology, National Hospital Organization, Asahikawa Medical Center, Asahikawa-city, Hokkaido, Japan.
Abstract:
Myotonic dystrophies (DMs) are autosomal dominant disorders with multisystemic clinical features. DMs are categorized as DM1, caused by a (CTG)n expansion mutation in 19q13, and DM2, caused by a (CCTG)n expansion mutation in 3q21. The clinical features of DM2 are diffuse and proximal dominant weakness, wasting, myotonia, cardiac problems, cataracts, and insulinresistance. DM2 is milder than DM1. We compared the clinical features of both DMs and studied a Japanese patient with DM2 who had expansion mutations different from those usually attributed to the disease and originally discovered by European researchers. The detailed clinical features of the Japanese DM2 patient are described.
Related Concept Videos
Alterations in Muscle Tone lll
Satellite Stem Cells and Muscular Dystrophy
Alterations in Muscle Tone ll
Cardiomyopathy II: Dilated Cardiomyopathy
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

